JOHN P. BRANCACCIO

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cardiff Oncology, Inc.

Filing Date Source Excerpt
2015-10-16 John P. Brancaccio As of December 31, 2014, 121,701 stock options were outstanding, of which 103,417 were exercisable.

Data sourced from SEC filings. Last updated: 2026-02-03